Weiwei Yang

832 total citations
29 papers, 672 citations indexed

About

Weiwei Yang is a scholar working on Neurology, Cellular and Molecular Neuroscience and Physiology. According to data from OpenAlex, Weiwei Yang has authored 29 papers receiving a total of 672 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Neurology, 13 papers in Cellular and Molecular Neuroscience and 8 papers in Physiology. Recurrent topics in Weiwei Yang's work include Parkinson's Disease Mechanisms and Treatments (21 papers), Neurological disorders and treatments (11 papers) and Alzheimer's disease research and treatments (5 papers). Weiwei Yang is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (21 papers), Neurological disorders and treatments (11 papers) and Alzheimer's disease research and treatments (5 papers). Weiwei Yang collaborates with scholars based in China and United States. Weiwei Yang's co-authors include Shun Yu, Hui Yang, Chen Duan, Xuran Li, Chunli Zhao, Zhifeng Qi, Xin Li, Xiaoxi Zhuang, Lingling Lu and Li Chen and has published in prestigious journals such as Journal of Molecular Biology, Neuroscience and Human Molecular Genetics.

In The Last Decade

Weiwei Yang

29 papers receiving 665 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Weiwei Yang China 16 374 226 197 195 109 29 672
Julianna J. Tomlinson Canada 12 353 0.9× 229 1.0× 394 2.0× 127 0.7× 113 1.0× 22 781
Jason Schapansky Canada 11 377 1.0× 345 1.5× 361 1.8× 188 1.0× 169 1.6× 16 901
Michelle Hiu-Wai Kung Hong Kong 12 268 0.7× 265 1.2× 222 1.1× 123 0.6× 133 1.2× 16 639
Marialuisa Quadri Netherlands 16 605 1.6× 254 1.1× 261 1.3× 256 1.3× 89 0.8× 22 1.2k
Wendy Strong Canada 13 473 1.3× 313 1.4× 166 0.8× 86 0.4× 52 0.5× 16 765
Jaegwon Chung United States 13 262 0.7× 205 0.9× 153 0.8× 144 0.7× 45 0.4× 17 709
Hironori Yokoyama Japan 17 282 0.8× 183 0.8× 89 0.5× 261 1.3× 40 0.4× 32 684
Alvin Joselin Canada 8 260 0.7× 343 1.5× 151 0.8× 121 0.6× 157 1.4× 12 636
Md Shahaduzzaman United States 10 165 0.4× 217 1.0× 204 1.0× 120 0.6× 68 0.6× 10 629

Countries citing papers authored by Weiwei Yang

Since Specialization
Citations

This map shows the geographic impact of Weiwei Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiwei Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiwei Yang more than expected).

Fields of papers citing papers by Weiwei Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weiwei Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiwei Yang. The network helps show where Weiwei Yang may publish in the future.

Co-authorship network of co-authors of Weiwei Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Weiwei Yang. A scholar is included among the top collaborators of Weiwei Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weiwei Yang. Weiwei Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Jie, Runxiang Yang, Hao Wu, et al.. (2024). 1278P Update of the INSPIRE study: Iruplinalkib versus crizotinib in ALK TKI-naïve locally advanced or metastatic ALK+ non-small cell lung cancer (NSCLC). Annals of Oncology. 35. S815–S815. 1 indexed citations
2.
Yang, Weiwei, Shengli Xu, Ming Zhou, & Piu Chan. (2024). Aging-related biomarkers for the diagnosis of Parkinson’s disease based on bioinformatics analysis and machine learning. Aging. 16(17). 12191–12208. 1 indexed citations
3.
Xu, Qi, et al.. (2023). Swimming prevents cell death of chondrocytes via PI3K/AKT pathway in an experimental model. Journal of Orthopaedic Surgery and Research. 18(1). 439–439. 3 indexed citations
4.
Li, Xuying, Xin Li, Xuran Li, et al.. (2021). Alterations of Erythrocytic Phosphorylated Alpha-Synuclein in Different Subtypes and Stages of Parkinson's Disease. Frontiers in Aging Neuroscience. 13. 623977–623977. 22 indexed citations
5.
Wang, Huijuan, Jingzhu Zhao, Linfei Hu, et al.. (2020). Apatinib Inhibits Cell Proliferation and Induces Autophagy in Human Papillary Thyroid Carcinoma via the PI3K/Akt/mTOR Signaling Pathway. Frontiers in Oncology. 10. 217–217. 38 indexed citations
6.
7.
Yang, Weiwei, et al.. (2020). Alpha-synuclein differentially reduces surface expression of N-methyl-d-aspartate receptors in the aging human brain. Neurobiology of Aging. 90. 24–32. 9 indexed citations
8.
Yang, Weiwei, et al.. (2020). Increased α-synuclein oligomerization is associated with decreased activity of glucocerebrosidase in the aging human striatum and hippocampus. Neuroscience Letters. 733. 135093–135093. 6 indexed citations
9.
Yang, Weiwei, Xuran Li, Xin Li, & Shun Yu. (2020). Hemoglobin-α-synuclein complex exhibited age-dependent alterations in the human striatum and peripheral RBCs. Neuroscience Letters. 736. 135274–135274. 15 indexed citations
10.
Yang, Weiwei, et al.. (2019). Alpha-synuclein oligomerization increases its effect on promoting NMDA receptor internalization.. Europe PMC (PubMed Central). 12(1). 87–100. 12 indexed citations
11.
Li, Xuran, Weiwei Yang, Xin Li, et al.. (2019). Alpha-synuclein oligomerization and dopaminergic degeneration occur synchronously in the brain and colon of MPTP-intoxicated parkinsonian monkeys. Neuroscience Letters. 716. 134640–134640. 22 indexed citations
12.
Li, Xin, Weiwei Yang, Xuran Li, et al.. (2017). Age-dependent elevations of oligomeric and phosphorylated alpha-synuclein synchronously occurs in the brain and gastrointestinal tract of cynomolgus monkeys. Neuroscience Letters. 662. 276–282. 13 indexed citations
13.
Yang, Weiwei & Shun Yu. (2016). Synucleinopathies: common features and hippocampal manifestations. Cellular and Molecular Life Sciences. 74(8). 1485–1501. 29 indexed citations
14.
Gao, Hua, et al.. (2015). Protein Phosphatase 2A is Involved in the Tyrosine Hydroxylase Phosphorylation Regulated by α-Synuclein. Neurochemical Research. 40(3). 428–437. 16 indexed citations
15.
Chen, Yunliu, Weiwei Yang, Xuying Li, et al.. (2015). α-Synuclein-induced internalization of NMDA receptors in hippocampal neurons is associated with reduced inward current and Ca2+ influx upon NMDA stimulation. Neuroscience. 300. 297–306. 27 indexed citations
16.
17.
Yang, Weiwei, et al.. (2013). Alpha-synuclein overexpression increases phospho-protein phosphatase 2A levels via formation of calmodulin/Src complex. Neurochemistry International. 63(3). 180–194. 30 indexed citations
18.
Gao, Hong‐Li, Weiwei Yang, Zhifeng Qi, et al.. (2012). DJ-1 Protects Dopaminergic Neurons against Rotenone-Induced Apoptosis by Enhancing ERK-Dependent Mitophagy. Journal of Molecular Biology. 423(2). 232–248. 105 indexed citations
19.
Zhang, Nan, Yanling Yin, Song Han, et al.. (2011). Hypoxic preconditioning induced neuroprotection against cerebral ischemic injuries and its cPKCγ-mediated molecular mechanism. Neurochemistry International. 58(6). 684–692. 45 indexed citations
20.
Yang, Weiwei, Li Chen, Yunmin Ding, Xiaoxi Zhuang, & Un Jung Kang. (2007). Paraquat induces dopaminergic dysfunction and proteasome impairment in DJ-1-deficient mice. Human Molecular Genetics. 16(23). 2900–2910. 78 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Julianna J. Tomlinson Breakdown of academic impact, for papers by Jason Schapansky Breakdown of academic impact, for papers by Michelle Hiu-Wai Kung Breakdown of academic impact, for papers by Marialuisa Quadri Breakdown of academic impact, for papers by Wendy Strong Breakdown of academic impact, for papers by Jaegwon Chung Breakdown of academic impact, for papers by Hironori Yokoyama Breakdown of academic impact, for papers by Alvin Joselin Breakdown of academic impact, for papers by Md Shahaduzzaman
Rankless by CCL
2026